ENDRA Life Sciences Inc.·4

Aug 24, 8:55 AM ET

Tokman Alexander Y 4

4 · ENDRA Life Sciences Inc. · Filed Aug 24, 2022

Insider Transaction Report

Form 4
Period: 2022-08-22
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-08-22$0.26/sh+20,000$5,200152,857 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION